Insights

Precision growth Capitalizing on DELFI's scalable whole-genome cfDNA platform and AI-driven analytics, propose partnerships or pilot programs with mid to large diagnostics companies and hospital networks seeking to expand liquid biopsy offerings for early cancer detection and monitoring.

Strategic partnerships Target opportunities with sequencing, AI, and cloud infrastructure players (AWS, data analytics vendors) to co-develop or accelerate deployment of DELFI’s technology in clinical workflows, increasing reach in integrated healthcare solutions.

R&D leverage Position DELFI for collaborations with pharmaceutical and biotech firms pursuing cfDNA fragmentomics biomarkers for trial enrichment, treatment monitoring, or companion diagnostics, leveraging existing publications and conference showcases.

Executive engagement Engage newly joined board member and CFO in strategic fundraising and commercial expansion discussions, aligning on go-to-market plans, larger enterprise deployments, and potential strategic investment.

Market readiness Highlight strong conference presence and ongoing clinical validation at AACR and ATS events to pursue enterprise deployments with health systems and diagnostics networks seeking validated, non-invasive cancer detection tools.

DELFI Diagnostics Tech Stack

DELFI Diagnostics uses 8 technology products and services including iCIMS, Amazon Web Services, WordPress, and more. Explore DELFI Diagnostics's tech stack below.

iCIMS

Applicant Tracking Systems

Amazon Web Services

Cloud Hosting

WordPress

Content Management System

Adobe Experience Cloud

Data Management Platforms

E-commerce

Miscellaneous

Team Collaboration

Web Analytics

DELFI Diagnostics Email Formats	Example	Percentage
Last@delfidiagnostics.com	Doe@delfidiagnostics.com	73%
First.Last@delfidiagnostics.com	John.Doe@delfidiagnostics.com	26%
First@delfidiagnostics.com	John@delfidiagnostics.com	1%

DELFI Diagnostics Email Formats

Example

Percentage

Last@delfidiagnostics.com

Doe@delfidiagnostics.com

73%

First.Last@delfidiagnostics.com

John.Doe@delfidiagnostics.com

26%

First@delfidiagnostics.com

John@delfidiagnostics.com

Frequently Asked Questions

What is DELFI Diagnostics's official website and social media links?

DELFI Diagnostics's official website is delfidiagnostics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does DELFI Diagnostics generate?

As of August 2026, DELFI Diagnostics's annual revenue is estimated to be $25M - $50M.

What is DELFI Diagnostics's NAICS code?

DELFI Diagnostics's NAICS code is 6215 - Medical and Diagnostic Laboratories.

How many employees does DELFI Diagnostics have currently?

As of August 2026, DELFI Diagnostics has approximately 151 employees across 5 continents, including North America, Africa and Asia. Key team members include Chief People Officer: A. D., Chief Commercial Officer: J. M. and Vice President Medical Affairs: S. L. M. Explore DELFI Diagnostics's employee directory with LeadIQ.

What industry does DELFI Diagnostics belong to?

DELFI Diagnostics operates in the Medical and Diagnostic Laboratories industry.

What technology does DELFI Diagnostics use?

DELFI Diagnostics's tech stack includes iCIMS, Amazon Web Services, WordPress, Adobe Experience Cloud, Shopify, DocuSign, Box and Piwik PRO Core.

What is DELFI Diagnostics's email format?

DELFI Diagnostics's email format typically follows the pattern of Last@delfidiagnostics.com. Find more DELFI Diagnostics email formats with LeadIQ.

How much funding has DELFI Diagnostics raised to date?

As of August 2026, DELFI Diagnostics has raised $366M in funding. The last funding round occurred on Dec 18, 2025 for $225M.

When was DELFI Diagnostics founded?

DELFI Diagnostics was founded in 2019.

DELFI Diagnostics

Q: How many employees does DELFI Diagnostics have currently?

DELFI Diagnostics has approximately 151 employees.

Q: What technology does DELFI Diagnostics use?

DELFI Diagnostics's tech stack includes Really Simple Discovery, Google Maps, Gravity Forms, Google Analytics, X-Content-Type-Options.

Q: What is DELFI Diagnostics's NAICS code?

DELFI Diagnostics's NAICS code is 6215 (Medical and Diagnostic Laboratories).

Medical and Diagnostic LaboratoriesCalifornia, United States51-200 Employees

Delfi Diagnostics develops blood-based tests to detect and monitor cancer by analyzing patterns of DNA fragmentation in a patient’s blood. The tests rely on genome-wide analysis of circulating DNA to identify signals associated with cancer, offering a noninvasive option for early detection and ongoing disease tracking. In oncology, the company serves pharmaceutical companies seeking objective data to inform drug development decisions.

Based in Palo Alto, California, the company operates in the medical and diagnostic laboratories sector, positioned at the intersection of genomics and cancer diagnostics. It is a relatively small to mid-sized organization focused on blood-based genomic testing. In April 2026, Delfi announced the appointment of Charles Newton to its board of directors.

Insights

Similar companies to DELFI Diagnostics